MRI In-bore Biopsy

The MR-guided in-bore biopsy represents a remarkable advancement in prostate cancer diagnosis by significantly reducing uncertainties and errors in the process. In-bore biopsy is typically used to collect 2-3 samples of tumor suspicious areas only and thereby lowering the number of overall cores and complications. The real-time MRI feedback of the needle guide location provides high confidence of the biopsy results and true aggressiveness of potential prostate cancer.

Traditional biopsy methods often had limitations in terms of precision and the ability to accurately locate and target suspicious lesions. With Soteria’s innovative approach, physicians are enabled to detect prostate cancer earlier and treat more precisely. It is a significant step forward in the battle against this common form of cancer, improving patients’ prognosis and optimizing treatment options.

Benefits of In-bore Biopsy

• High precision: In-bore biopsy offers exceptional precision and accuracy in targeting suspicious areas within the prostate, reducing the likelihood of false-negative results.
• Increased confidence: In-bore biopsy minimizes the risk of sampling errors, ensuring that biopsy cores are taken from the exact tumor suspicious areas.
• Tailored treatment plans: The precise information obtained from in-bore biopsies helps in the development of personalized treatment plans based on the location and aggressiveness of the cancer.

In-bore biopsy is considered a valuable tool in the diagnosis and risk assessment of prostate cancer, especially when highly detailed imaging and precise targeting of suspicious areas are required by combining high sensitivity with high specificity. It offers significant advantages in terms of accuracy and helps to guide treatment decisions for patients.